Activity of antiphospholipid antibody ELISA cofactor in different animal sera
- 1 January 1994
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 8 (3) , 167-171
- https://doi.org/10.1002/jcla.1860080310
Abstract
A plasma protein cofactor, β2-glycoprotein I (β2GPI), also known as apolipoprotein H, is necessary to detect certain antiphospholipid antibodies (aPA) to negatively charged phospholipids (PL) in the ELISA. Inasmuch as sera are diluted 1:100 before testing, the concentration of native β2GPI may be insufficient to provide an optimal aPA ELISA signal. Therefore, many laboratories add adult bovine serum (ABS) to the diluent buffer to provide a consistent level of cofactor for optimal aPA binding. To determine if other animal sera can provide the cofactor, cat, chicken, dog, horse, goat, guinea pig, mouse, pig, rat, and sheep were tested as diluent supplements in the aPA ELISA. To measure cofactor activity in these animal sera, ELISA for aPA to anionic phospholipids were performed. Two aPA positive patient plasmas were selected for study; one with cofactordependent and one with cofactor-independent aPA. Only four of the animal sera tested (bovine, pig, sheep, and cat) supported the cofactor-dependent aPA in ELISA. The cofactor-independent aPA was positive in the presence of each animal serum except bovine and rat. In order to determine whether these animal sera contain a β2GPI-like molecule, Western blot analyses were performed. By using a polyclonal antiserum produced to human β2GPI, specific β2GPI-like cross-reactivity was observed with all animal sera except the chicken. In summary, cofactor activity in animal sera varied significantly; however, bovine and pig sera appear to allow optimal binding of cofactor dependent aPA.Keywords
This publication has 10 references indexed in Scilit:
- Changes in β2-Glycoprotein I Antigenicity Induced by Phospholipid BindingThrombosis and Haemostasis, 1993
- Interaction of heparin with β2-glycoprotein I and antiphospholipid antibodiesThrombosis Research, 1992
- Laboratory and clinical features in systemic lupus erythematosus patients with or without anticardiolipin antibodiesThrombosis Research, 1991
- Anticardiolipin antibodies in systemic lupus erythematosus. Association with thrombosis if measured by ELISA with adult bovine serum as buffer rather than fetal calf serumThrombosis Research, 1990
- Anticardiolipin cofactor(s) and differential diagnosis of autoimmune diseaseThe Lancet, 1990
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive PatientsMedicine, 1989
- β2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesiclesInternational Journal of Biochemistry, 1984